[1] | Varo R, Chaccour C, Bassat Q. Update on malaria[J]. Med Clin (Barc), 2020, 155(9): 395-402. | [2] | Yin JH, Lengeler C, Tanner M, et al. A malaria-free China: global importance and key experience[J]. Adv Parasitol, 2022, 116: xv-xix. | [3] | Feng J, Tu H, Zhang L, et al. Imported malaria cases: China, 2012-2018[J]. China CDC Weekly, 2020, 2(17): 277-283. | [4] | Zhang T, Jiang JJ, Lyu XF, et al. Surveillance and response to imported malaria during the COVID-19 epidemic―Anhui Province, China, 2019-2021[J]. China CDC Weekly, 2022, 4(28): 622-625. | [5] | Balerdi-Sarasola L, Mu?oz J, Fleitas P, et al. Not all severe malaria cases are severe: is it time to redefine severity criteria for malaria in non-endemic regions?[J]. Travel Med Infect Dis. 2024, 60: 102740. | [6] | World Health Organization. WHO Guidelines for malaria[EB/OL]. (2022-02-18)[2024-06-14]. https://www.who.int/. | [7] | Expert Group of National Center for Infectious Diseases. Guidelines for malaria diagnosis and treatment[J]. Chin J Parasitol Parasit Dis, 2022, 40(4): 419-427. (in Chinese) | | (国家传染病医学中心撰写组. 疟疾诊疗指南[J]. 中国寄生虫学与寄生虫病杂志, 2022, 40(4): 419-427.) | [8] | Yi J, Wu DN, Dong XR, et al. Analysis of laboratory detection capability for imported malaria in Hubei Province before and after malaria elimination[J]. Chin J Parasitol Parasit Dis, 2024, 42(2): 177-181, 190. (in Chinese) | | (易佳, 吴冬妮, 董小蓉, 等. 湖北省消除疟疾前后输入性疟疾实验室检测能力分析[J]. 中国寄生虫学与寄生虫病杂志, 2024, 42(2): 177-181, 190.) | [9] | Balaji SN, Deshmukh R, Trivedi V. Severe malaria: biology, clinical manifestation, pathogenesis and consequences[J]. J Vector Borne Dis, 2020, 57(1): 1-13. | [10] | Venkatesan P. The 2023 WHO World malaria report[J]. Lancet Microbe, 2024, 5(3): e214. | [11] | Wen J, Guo MQ, Zhang B, et al. Epidemiological analysis of imported malaria in Shanghai Public Health Clinical Center from 2012 to 2022[J]. Chin J Parasitol Parasit Dis, 2024, 42(2): 147-152. (in Chinese) | | (文静, 郭明权, 张蓓, 等. 2012—2022年上海市公共卫生临床中心输入性疟疾病例流行病学分析[J]. 中国寄生虫学与寄生虫病杂志, 2024, 42(2): 147-152.) | [12] | Zhuang SF, Li ZX, Peng JP, et al. Evaluation on malaria elimination process and strategy in Hunan Province[J]. Pract Prev Med, 2022, 29(11): 1281-1285. (in Chinese) | | (庄世锋, 李正祥, 彭进平, 等. 湖南省消除疟疾历程及策略评价[J]. 实用预防医学, 2022, 29(11): 1281-1285.) | [13] | Chen F, He JA, Dong RL, et al. Application of SPR protein chip in screening for imported malaria[J]. Chin J Biotechnol, 2021, 37(4): 1360-1367. (in Chinese) | | (陈凡, 何建安, 董瑞玲, 等. SPR蛋白质芯片在输入性疟疾筛查中的应用[J]. 生物工程学报, 2021, 37(4): 1360-1367.) | [14] | Zhang X, Ruan W, Wang XX, et al. Epidemiological characteristics of imported severe malaria cases in Zhejiang Province from 2012-2020[J]. Chin J Parasitol Parasit Dis, 2021, 39(4): 466-472. (in Chinese) | | (张轩, 阮卫, 王笑笑, 等. 浙江省2012—2020年输入性疟疾重症病例流行特征分析[J]. 中国寄生虫学与寄生虫病杂志, 2021, 39(4): 466-472.) | [15] | Han CX, Sun AJ, Li YT, et al. Epidemiological and clinical characteristics of imported malaria in Dalian from 2013 to 2018[J]. Chin J Endem, 2019, 38(10): 835-839. (in Chinese) | | (韩常新, 孙艾军, 李雨婷, 等. 2013—2018年大连市输入性疟疾的流行病学及临床特征分析[J]. 中华地方病学杂志, 2019, 38(10): 835-839.) | [16] | Jin H, Huang L, Wang L. Analysis of risk factors associated with prolonged hospital stay for imported malaria cases in Chengdu[J]. Sichuan Med J, 2022, 43(1): 67-71. (in Chinese) | | (金鸿, 黄亮, 王林. 成都市输入性疟疾患者住院时间延长危险因素分析[J]. 四川医学, 2022, 43(1): 67-71.) | [17] | He ZY, Wang XM, Li X, et al. Comparative analysis of severe and general malaria cases in Beijing, 2013-2020[J]. Cap J Public Health, 2021, 15(4): 197-199. (in Chinese) | | (何战英, 王小梅, 李旭, 等. 2013—2020年北京市重症和普通疟疾病例特征比较分析[J]. 首都公共卫生, 2021, 15(4): 197-199.) | [18] | Xu Y, Wang LJ, Kong XL, et al. Epidemiological characteristics of imported malaria in Shandong Province in 2017-2022[J]. Chin J Parasitol Parasit Dis, 2024, 42(2): 140-146. (in Chinese) | | (许艳, 王龙江, 孔祥礼, 等. 2017—2022年山东省输入性疟疾流行病学特征[J]. 中国寄生虫学与寄生虫病杂志, 2024, 42(2): 140-146.) | [19] | Groomes PV, Kanjee U, Duraisingh MT. RBC membrane biomechanics and Plasmodium falciparum invasion: probing beyond ligand-receptor interactions[J]. Trends Parasitol, 2022, 38(4): 302-315. | [20] | Antwi-Baffour S, Mensah BT, Johnson G, et al. Haematological parameters and their correlation with the degree of malaria parasitaemia among outpatients attending a polyclinic[J]. Malar J, 2023, 22(1): 281. | [21] | Gao XS, Guo J, Duan XF. Changes and clinical significance of the inflammatory markers in patients with malaria[J]. Chin J Exp Clin Infect Dis Electron Ed, 2018, 12(3): 240-243. (in Chinese) | | (高学松, 郭江, 段雪飞. 疟疾患者炎症指标变化特点及临床意义[J]. 中华实验和临床感染病杂志(电子版), 2018, 12(3): 240-243.) | [22] | Asare R, Opoku-Okrah C, Danquah KO, et al. Assessment of platelet indices and platelet activation markers in children with Plasmodium falciparum malaria[J]. Malar J, 2020, 19(1): 143. | [23] | Mita-Mendoza NK, Magallon-Tejada A, Parmar P, et al. Dimethyl fumarate reduces TNF and Plasmodium falciparum induced brain endothelium activation in vitro[J]. Malar J, 2020, 19(1): 376. | [24] | Cha SJ, Yu X, Gregory BD, et al. Identification of key determinants of cerebral malaria development and inhibition pathways[J]. mBio, 2022, 13(1): e0370821. | [25] | Shonhai A. The role of Hsp70s in the development and pathogenicity of Plasmodium falciparum[J]. Adv Exp Med Biol, 2021, 1340: 75-95. | [26] | Wu DN, Zhang HX, Zhu H, et al. Characteristics of imported malaria cases in Hubei Province from 2016 to 2020[J]. Chin J Parasitol Parasit Dis, 2021, 39(5): 585-591. (in Chinese) | | (吴冬妮, 张华勋, 朱红, 等. 2016—2020年湖北省输入性疟疾病例特征分析[J]. 中国寄生虫学与寄生虫病杂志, 2021, 39(5): 585-591.) | [27] | Cao S, Wang L. Malaria epidemic situation and its control strategy from 1952 to 2018 in Yangpu District of Shanghai[J]. Shanghai J Prev Med, 2019, 31(11): 907-910. (in Chinese) | | (曹慎, 王琳. 上海市杨浦区1952—2018年疟疾疫情和防治策略研究[J]. 上海预防医学, 2019, 31(11): 907-910.) |
|